Filter
1093
Filtered Results: 1093
Text search:
reagents
Featured
Recommendations
131
New Publications
325
Language
Document type
No document type
620
Guidelines
186
Studies & Reports
123
Strategic & Response Plan
69
Manuals
64
Fact sheets
12
Training Material
9
Situation Updates
8
Brochures
1
Infographics
1
Countries / Regions
India
72
Brazil
34
Ethiopia
33
Kenya
30
Nigeria
29
Tanzania
29
Malawi
27
Uganda
27
Sierra Leone
25
Liberia
25
Africa
22
Rwanda
20
Global
20
Ghana
19
Zimbabwe
19
Mozambique
18
Western and Central Europe
18
Zambia
18
Latin America and the Carribbean
17
Nepal
15
Bangladesh
13
Congo, Democratic Republic of
12
West and Central Africa
12
East and Southern Africa
12
Senegal
9
Eastern Europe
9
Syria
8
South Africa
8
Namibia
8
Angola
8
Botswana
8
Ukraine
7
Lesotho
7
Burkina Faso
7
Myanmar / Burma
7
Haiti
6
Cambodia
6
Venezuela
6
Western Pacific Region
6
Middle East and North Africa
5
Russia
5
Indonesia
5
Eswatini/ Swaziland
5
Colombia
4
Guinea
4
USA
4
South–East Asia Region
4
Eastern Europe and Central Asia
4
Cameroon
3
Albania
3
Peru
3
Philippines
3
Guinea-Bissau
3
Germany
3
Iraq
3
Pakistan
3
Togo
2
Afghanistan
2
Asia
2
Turkmenistan
2
Bolivia
2
Argentina
2
Papua New Guinea
2
Sri Lanka
2
Yemen
2
Mali
2
South Sudan
2
Somalia
2
Madagascar
2
Tajikistan
1
Timor Leste/ East Timor
1
Turkey
1
Benin
1
Chile
1
Iran
1
Fiji
1
Burundi
1
Mongolia
1
North America
1
Japan
1
Mauritius
1
Portugal
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Sudan
1
Georgia
1
Central African Republic
1
Chad
1
Libya
1
Bhutan
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
517
Clinical Guidelines
103
Pharmacy & Technologies
79
Key Resources
37
Public Health
35
Women & Child Health
13
Capacity Building
5
Toolboxes
COVID-19
131
TB
110
Rapid Response
83
HIV
80
NTDs
45
AMR
44
Pharmacy
39
Ebola
29
Planetary Health
17
Zika
15
Cholera
14
Caregiver
14
Natural Hazards
13
Conflict
9
Polio
8
Mental Health
7
Health Financing Toolbox
5
Refugee
4
NCDs
3
Global Health Education
3
Specific Hazards
2
Typhoon
1
Japan has been implementing projects of global extension of medical technologies under an official development assistance policy to improve public health and medicine by promoting Japanese medical technologies worldwide. The current work examines the impact and goals of implementing this new scheme....
Cholera is a major health risk in many parts of the world, affecting millions of people every year. Since mid-2021, the world has been facing an acute upsurge of the 7th cholera pandemic, which is characterized by the number, size and concurrence of multiple outbreaks, the spread to areas that had b...
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant...
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current ...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
A global Pandemic, Preparedness and Response (RRR) architecture
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
At the global, national, and regional levels, there are several guidelines and guides regarding the preparedness, prevention, surveillance, and control of diseases caused by respiratory viruses; most initiatives focus on specific virus events or cases. During the coronavirus disease 2019 (COVID-19) ...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
Mpox is a zoonotic disease caused by a double-stranded DNA virus that belongs to the Orthopoxvirus genus of the Poxviridae family. The disease presents with symptoms similar to smallpox but with a lesser severity. It was first discovered in 1958 when two outbreaks of a poxlike disease occurred in co...
This status report shows how far we have come—and how much further we must go—if we hope to meet the global commitments to end AIDS in children. It offers a snapshot of global progress and permits an early assessment of the impact of the Global Alliance’s work.
This report provides an overview of the operations and activities of the WHO Country Office in Ukraine in 2023. Despite the acute health impacts of the war in Ukraine, the Country Office continued its work according to its core mandate. WHO supported the Government of Ukraine in managing the health ...
On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union...
PEPFAR Malawi’s Country Operational Plan 2022 (COP22) embodies joint priorities from national and subnational dialogues building on the 2020-2025 National Strategic Plan for HIV/AIDS. The interagency team has developed a person-centered, district-tailored and Malawi Population-Based HIV Impact Ass...
PEPFAR Malawi’s Country Operational Plan (COP) 2021 reflects a culmination of strong interagency collaboration between the PEPFAR Malawi team, Government of Malawi (GoM), and civil society organizations (CSOs) to mitigate the devastating impacts of COVID-19 and sustain progress achieved over the l...
Malawi is a landlocked country with a surface area of 118,484 km2. Administratively, the country is divided into three regions, namely the Northern, Central and Southern regions. The country has 28 districts, which are further divided into traditional authorities (TA) ruled by chiefs. The TAs are su...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
The target audience of this document (and the associated online companion tool) includes WHO country offices
in Member States of the African Region; Member States’ ministries of health and their public health emergency
operation centres; relevant external assessment teams; and partners looking...
